Align Technology, Inc.

ALGN ·Healthcare, Medical Devices, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Operating Activities
Net Income $410.4M $421.4M $445.1M $361.6M $772.0M $1.78B $442.8M $400.2M
Depreciation & Amortization $237.4M $145.0M $142.4M $125.8M $108.7M $93.5M $79.0M $54.7M
Depreciation $218.6M $126.2M $126.0M $109.8M $92.1M $80.1M $73.1M —
Amortization $18.8M $18.9M $16.4M $16.0M $16.6M $13.4M $5.9M $6.0M
Stock-Based Compensation $185.9M $173.7M $154.0M $133.4M $114.3M $98.4M $88.2M $70.8M
Net Cash from Operating Activities $593.2M $738.2M $785.8M $568.7M $1.17B $662.2M $747.3M $554.7M
Investing Activities
Capital Expenditures $102.4M $115.6M $177.7M $291.9M $401.1M $154.9M $149.7M $223.3M
Business Acquisitions $0 $77.1M $0 $12.3M $8.0M $420.8M $0 $0
Net Cash from Investing Activities $-112.4M $-254.9M $-195.9M $-213.3M $-563.4M $-231.5M $-350.4M $6.9M
Financing Activities
Dividends Paid — — — — — — — —
Stock Repurchases $465.9M $352.9M $592.4M $435.0M $375.0M $0 $400.0M $300.0M
Net Cash from Financing Activities $-464.6M $-355.7M $-598.3M $-501.7M $-458.3M $-30.8M $-485.5M $-369.4M
Net Change in Cash $51.2M $106.4M $-3.8M $-157.8M $138.7M $410.3M $-86.4M $187.4M
Free Cash Flow $490.8M $622.7M $608.1M $276.8M $771.4M $507.3M $597.6M $331.4M
← Newer Page 1 of 3 Older →